To understand whether neutrophils were also altered in the bone marrow when an EZH2 inhibitor was administered, we performed scRNA-seq on the bone marrow of the same mice used for the tumor analysis (Supplementary Fig. S6A). Here, EZH2 is linked to neoplasm.